Rigel Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 230K 12K 2025-03
AstraZeneca USD 388M 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Celldex Therapeutics USD 66K 0 2025-03
Daiichi Sankyo JPY 50B 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Halozyme Therapeutics USD 123K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Ligand Pharmaceuticals USD 20K 0 2025-03
MacroGenics USD 628K 1000 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Veracyte USD 78K 1000 2024-12



Rigel Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.